FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder

Posted on by admin

Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia.

Leave a Reply

Your email address will not be published. Required fields are marked *